IMA (ImageneBio) PS Ratio: (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMA ImageneBio Inc IMA
10 GF Score
Price $5.59
! 3 Warning Signs
View Full Analysis

What is ImageneBio PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, ImageneBio's share price is $5.59. ImageneBio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Hence, ImageneBio's PS Ratio for today is .

The historical rank and industry rank for ImageneBio's PS Ratio or its related term are showing as below:

IMA' s PS Ratio Range Over the Past 10 Years
Min: 20.03   Med: 81.81   Max: 120.97
Current: 34.09

During the past 3 years, ImageneBio's highest PS Ratio was 120.97. The lowest was 20.03. And the median was 81.81.

IMA's PS Ratio is ranked worse than
75.24% of 929 companies
in the Biotechnology industry
Industry Median: 9.03 vs IMA: 34.09

ImageneBio's Revenue per Sharefor the three months ended in Mar. 2026 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

Warning Sign:

ImageneBio Inc revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of ImageneBio was -47.60% per year.

Back to Basics: PS Ratio


ImageneBio  (NAS:IMA) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


ImageneBio PS Ratio Related Terms


ImageneBio PS Ratio Historical Data

* Premium members only.

The historical data trend for ImageneBio's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImageneBio PS Ratio Chart

ImageneBio Annual Data
Trend Dec23 Dec24 Dec25
PS Ratio
0.00 0.00 42.07

ImageneBio Quarterly Data
Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial 0.00 0.00 113.19 42.07 0.00

IMA vs HYFT, CING, CRDF: PS Ratio Comparison

For the Biotechnology subindustry, ImageneBio's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImageneBio PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImageneBio's PS Ratio distribution charts can be found below:

* The bar in red indicates where ImageneBio's PS Ratio falls into.


IMA
10GF Score
ImageneBio Inc IMA
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ImageneBio PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

ImageneBio's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=5.59/0
=

ImageneBio's Share Price of today is $5.59.
ImageneBio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


ImageneBio Business Description

Address 12526 High Bluff Drive, Suite 345, San Diego, CA, USA, 92130
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
10GF Score

Get the complete analysis for IMA

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.59
Price